HPV and Vaccination
1 Dose of HPV Vaccine May Offer Protection
Two large international trials suggest single immunization may be as good as two or three.
By Robert Preidt, HealthDay News
Don't Miss This
Sign Up for OurCancer Care and PreventionNewsletter
Thanks for signing up!You might also like these other newsletters:
One dose of the human papillomavirus (HPV) vaccine Cervarix could prevent as many cases of cervical cancer as the current two- and three-dose schedules, a new study contends.
The vaccine protects against HPV types 16 and 18, which are believed to cause about 70 percent of cervical cancers. The vaccine was originally approved to be given in three doses over six months, but many countries are switching to a two-dose schedule in teenagers. The U.S. Centers for Disease Control and Prevention still recommends three doses for young Americans.
Researchers conducted two large phase 3 clinical trials that included more than 26,000 women between the ages of 15 and 25. They lived in North America, Latin America, Europe and Asia.
The researchers found that one dose of Cervarix offered similar levels of protection over four years when compared to two and three doses.
The findings were published online June 9 in The Lancet Oncology. Cervarix maker GlaxoSmithKline provided funding for one of the studies.
"Our findings question the number of HPV vaccine doses truly needed to protect the majority of women against cervical cancer, and suggest that a one-dose schedule should be further evaluated," co-study author Aimee Kreimer, of the U.S. National Cancer Institute, said in a journal news release.
RELATED: HPV Vaccine is Underutilized Due to Misconceptions, Lack of Education
"If one dose is sufficient, it could reduce vaccination and administration costs, as well as improve uptake. This is especially important in less developed regions of the world where more than 80 percent of cervical cancer cases occur," she explained.
However, further research is needed before vaccination guidelines can be changed, according to co-lead study author Cosette Wheeler, of the University of New Mexico Health Sciences Center in Albuquerque. She said researchers need to conduct trials lasting longer than four years to see how long the protection from one dose lasts.
But the idea of a one-dose vaccine is certainly a welcome one, experts said.
"If HPV vaccines could be delivered as one dose, while retaining their efficacy [effectiveness] against the most oncogenic HPV types 16 and 18, the global burden of cervical cancer would substantially decrease," Dr. Julia Brotherton, of the Victorian Cytology Service Registries in Melbourne, Australia, said in the news release.
Video: Dr. Gregory Poland discusses HPV vaccine
Loose, Long Fishtail Braided Hairstyle
Nike Could Be Involved In FIFAs Latest Corruption Scandal
See Guccis First Store Under Alessandro Michele
How to Dye a Dress
Benefits Of Plank Exercise Everyday in Hindi
5 Foods That Work Wonders for Your Health AND Your Looks
How to Master Screamed Vocals
Circumcision and HPV Risk
30-Day Walk Your Way to Weight Loss Challenge
9 Easy Ways to Have A Great Girls Night Out Without Cheating on Your Diet
Flu Season Off to Slow Start, So Far